Brand vs. generic adverse event reporting patterns: an authorized generic-controlled evaluation of cardiovascular medications

অনুরূপ উপাদানগুলি

• Methodological considerations for comparison of brand versus generic versus authorized generic adverse event reports in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)
  অনুযায়ী: Rahman, Md. Motiur, অন্যান্য
  প্রকাশিত: (2017)
• Comparison of Brand versus Generic Antiepileptic Drug Adverse Event Reporting Rates in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)
  অনুযায়ী: Rahman, Md. Motiur, অন্যান্য
  প্রকাশিত: (2017)
• Mixed approach retrospective analyses of suicide and suicidal ideation for brand compared with generic central nervous system drugs
  অনুযায়ী: Cheng, Ning, অন্যান্য
  প্রকাশিত: (2018)
• Comparison of generic-to-brand switchback patterns for generic and authorized generic drugs
  অনুযায়ী: Hansen, Richard A., অন্যান্য
  প্রকাশিত: (2017)
• Comparison of outcomes following a switch from a brand to an authorized vs. independent generic drug
  অনুযায়ী: Hansen, Richard A., অন্যান্য
  প্রকাশিত: (2017)